在患有慢性阻塞性肺病 (AIRFLOW-3) 的患者中对有针对性的肺膜的随机化假冒对照试验
Pallav L Shah1, Dirk-Jan Slebos2, Richard Sue3
1Royal Brompton & Harefield National Health Service Trust, Chelsea & Westminster Hospital and Imperial College, London, United Kingdom.
American journal of respiratory and critical care medicine
|September 8, 2025
概括
在AIRFLOW-3试验中,发现向性肺膜 (TLD) 并没有减少COPD恶化. 然而,TLD确实改善了一些患者的呼吸障碍,这表明了未来研究的潜在响应者概况.
科学领域:
- 肺部病理学 肺部病理学
- 医疗器械 医疗器械
- 临床试验 临床试验
背景情况:
- 慢性阻塞性肺病 (COPD) 显著影响患者的生活质量和医疗保健系统.
- 向性肺透 (TLD) 是一种旨在减少COPD患者呼吸道过敏反应的研究程序.
- 在AIRFLOW-3试验中,研究了D'Nerva TLD系统在治疗COPD恶化的有效性.
研究的目的:
- 与最佳医疗治疗相比,评估TLD对COPD恶化的影响.
- 评估二次终点,包括生活质量,肺功能和症状得分.
主要方法:
- 一个1: 1随机,双盲,假控制试验 (AIRFLOW-3) 涉及388名有症状的COPD患者.
- 患者接受了TLD加最佳医疗治疗或假手术加最佳医疗治疗.
- 主要终点是12个月内第一个中度或重度COPD恶化的时间.
主要成果:
- 该试验未能达到其主要终点,在TLD和虚假组之间的COPD恶化没有显著差异 (HR,1.268;95%CI,0.988-1.628).
- 与假装组相比,TLD组在1年后出现了呼吸障碍的统计学上显著改善 (35.4%对24.1%,P=0.021).
- 后期分析表明,初级终点失败可能与患者的表型有关,特别是那些没有显著的肺气患者.
结论:
- AIRFLOW-3没有证明TLD可以减少COPD恶化.
- 在后期分析中确定了一个潜在的响应者概况,这需要进一步调查.
- 计划进行一项前性的多中心随机对照试验,以验证这些发现,并探索COPD特定表型中的TLD.
相关概念视频
01:29Chronic Obstructive Pulmonary Disease-V: Management
3.1K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.1K
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
3.1K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
3.1K
01:26COPD: Management Using Bronchodilators and Corticosteroids
741
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
741
01:22Chronic Obstructive Pulmonary Disease
2.3K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.3K
01:30Chronic Obstructive Pulmonary Disease-V: Nursing Management
5.1K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
5.1K